Trade Summary

4 months ago, Zook Anthony P., serving as CEO at Neogenomics Inc (NEO), purchased 17,900 shares at $5.58 per share, for a total transaction value of $99,954.00. Following this transaction, Zook Anthony P. now holds 56,966 shares of NEO.

This purchase represents a 46.00% increase in Zook Anthony P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 6, 2025, meaning the disclosure happened on the same day as the trade.

Neogenomics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.